Unit Head
Honorary Professor Rod Dawson
MBChB (Stell), FCP (SA), Cert. Pulm (SA)
Honorary Professor Rod Dawson established the Centre for Tuberculosis Research Innovation at the University of Cape Town Lung Institute in 2007. He is a qualified Consultant Pulmonologist and has a special interest in chest radiology, tuberculosis and HIV infection. Honorary Professor Rod Dawson was appointed Director of the University of Cape Town Lung Institute in 2016.
Centre for TB Research Innovation (CTBRI)
The mandate of the UCT Lung Institute is to address priority health issues through, education, research and service. Since 2008 CTBRI has conducted research into tuberculosis with focus areas of TB drug development, HIV/TB interaction, effects of smoking in TB and HIV and understanding adherence to medication in drug-resistant TB.
“Worldwide incidence of tuberculosis in 2019: 10 million cases”
“Worldwide 1,2 million deaths from tuberculosis”
“60% of deaths occur in only 6 countries: Malaysia, India, China, Nigeria, Pakistan and South Africa”
RELEVANCE
Advancing new treatment solutions for tuberculosis and HIV
EXCELLENCE
Setting the standard for clinical trials
RESPECT
Transforming life for our patients
The 2020 WHO Global Tuberculosis Report estimates that in 2019 there were 10 million cases of tuberculosis worldwide. Tuberculosis remains a top 10 cause of death with more than 1.2 milliion people dying annually. 60% of these deaths occur in only 6 countries: Malaysia, India, China, Nigeria, Pakistan and South Africa. TB is the principal cause of death in South Africa.
CTBRI news
19th May 2022
BTZ-043 was profiled in an early phase development study at the UCTLI, sponsored by the EDCTP and German funds in 2019
29th April 2022
UCT Lung Institute in partnership with Novartis and the Department of Health launched a ‘lab-in-a-cab’ mobile TB clinic